Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Research & Technology (R&T) Working Group

Research & Technology (R&T) Working Group

BACK

Research & Technology (R&T) Working Group

The Research & Technology Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between academics and healthcare organisations represented by the members of the Virtual Physiological Human Institute (VPHi) and industries engaged in the predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Creating links between the VPHi Membership and Avicenna Industry Members
  • Promotion of in silico medicine in Horizon Europe Program
  • Working towards the creation of a certified tissue library for biological materials
  • Work on credibility building for AI technologies and policy asks
  • Medical community outreach

Priorities in 2025 - 2027 and beyond:

2025:

  • Certified tissue library: finalise 1st campaign & start 2nd campaign
  • AI success stories compilation & policy input
  • Promote consortium formation within AA for Horizon Europe (calls WP ’23-’24)
  • Identification challenges for HEU WP ‘25-’27

2026:

  • Certified tissue library: 2nd campaign & EU funding applications
  • AI technology & policy input
  • Ecosystem digital twins in healthcare (EDITH)
  • Promote consortium formation within AA for Horizon Europe (calls WP ‘24)

2027 and beyond:

  • Consolidation certified tissue library
  • AI technology & policy input
  • Continue AA consortium building activities
  • Continuous development of EU-infrastructure for digital twins in healthcare & related ecosystem


Liesbet Geris

Liesbet Geris

Research & Technology Working Group Leader

Executive Director, VPH Institute

SEND E-MAIL
READ BIO

NEWS

News Avicenna Alliance at RAPS meeting in Pittsburgh

Avicenna Alliance at RAPS meeting in Pittsburgh

On October 8th, various key members of the Avicenna Alliance including Marc Horner, International Affairs WG leader, Martha de Cuhna, Policy Development WG Leader, and our new partner Surash Surash from the leading Notified Body TüV SüD, spoke at the Regulatory Affairs Professional Society (RAPS) meeting in Pittsburgh to highlight the essential and increasing role of in silico methods throughout the total product life cycle of medical devices.

News Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner

Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner

The Avicenna Alliance is delighted to welcome TÜV SÜD as its newest Partner. TÜV SÜD is a leading Notified Body operating across multiple regulatory territories, including the EU, the United States, the UK, and Asia. With more than 150 years of experience, a presence in 1,000 locations worldwide, and over 30,000 employees, TÜV SÜD is a trusted global partner in testing, inspection, certification, and training solutions.

News The Alliance at the iSi Health Symposium

The Alliance at the iSi Health Symposium

On 11 and 12 September 2025, our partner iSi Health, Erica Beaucage-Gauvreau and Rocio Castro Vinuelas, organised an excellent symposium in Leuven to bring together key players in the in silico community and promote networking, brainstorming and exchanges.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry